Inhibitor Therapeutics Statistics
Total Valuation
INTI has a market cap or net worth of 15.53 million. The enterprise value is 13.22 million.
| Market Cap | 15.53M |
| Enterprise Value | 13.22M |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INTI has 172.57 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 172.57M |
| Shares Outstanding | 172.57M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 37.56% |
| Owned by Institutions (%) | 1.74% |
| Float | 77.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -12.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.00 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.19
| Current Ratio | 3.19 |
| Quick Ratio | 3.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -952.30% and return on invested capital (ROIC) is -567.52%.
| Return on Equity (ROE) | -952.30% |
| Return on Assets (ROA) | -52.20% |
| Return on Invested Capital (ROIC) | -567.52% |
| Return on Capital Employed (ROCE) | -196.37% |
| Weighted Average Cost of Capital (WACC) | 2.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -550,056 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.57% in the last 52 weeks. The beta is -0.36, so INTI's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | +28.57% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 52.06 |
| Average Volume (20 Days) | 46,728 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.43M |
| Pretax Income | -3.30M |
| Net Income | -3.30M |
| EBITDA | n/a |
| EBIT | -3.43M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 2.38 million in cash and 61,613 in debt, with a net cash position of 2.31 million or 0.01 per share.
| Cash & Cash Equivalents | 2.38M |
| Total Debt | 61,613 |
| Net Cash | 2.31M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | -1.29M |
| Book Value Per Share | -0.01 |
| Working Capital | 1.68M |
Cash Flow
| Operating Cash Flow | -3.23M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | -21.25% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |